Can plant-derived extracellular vesicles help treat rheumatoid arthritis symptoms?

Plant-derived extracellular vesicles (PDEVs) are tiny particles from plants like ginger and ginseng that can carry bioactive molecules. In rheumatoid arthritis (RA), they are being studied as a possible treatment because they may calm inflammation and protect joints. However, this research is still very early — most studies have been done in cells or animals, not in people. There is no clinical evidence yet that PDEVs can help RA patients.

What the research says

A 2025 review summarized the potential of PDEVs for RA, noting they can modulate immune responses, suppress inflammation, and protect bone and cartilage ². The same review pointed out that most studies are in cell cultures or animal models, and clinical data are not yet available ².

Specific studies have shown promising results in animals. One 2025 study found that ginger-derived extracellular vesicles modified with folic acid targeted inflamed joints in mice and reduced RA symptoms by shifting immune cells from a pro-inflammatory to a healing state ⁹. Another 2025 study showed that ginseng-derived nanoparticles delivered a microRNA into joint macrophages, reducing inflammation through the KRAS-MAPK pathway ¹⁰.

While these findings are encouraging, the field faces challenges: lack of standardized production methods, variability in vesicle quality, and limited understanding of how they work in the human body ². Until human trials are done, it is not known if PDEVs are safe or effective for treating RA.

What to ask your doctor

• Are there any clinical trials of plant-derived extracellular vesicles for rheumatoid arthritis that I might join?
• What are the current standard treatments for RA, and how do they compare to experimental approaches like PDEVs?
• Could any plant-based supplements I take interfere with my RA medications?
• How can I stay informed about new research on natural therapies for RA?